ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv art policy culture

The Specter of Denialism
Nicoli Nattrass | Mar 1, 2012 | 3 min read
Conspiracy theories surrounding the global HIV/AIDS epidemic have cost thousands of lives. But science is fighting back.
AIDS Investigators Cautiously Applauding Recent Advances
Steven Benowitz | Sep 29, 1996 | 10+ min read
Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading
Mapping the Terrain
Thana Poopat and Nantiya Tangwisutijit | Jan 12, 2010 | 10+ min read
color = "#B693B5"; Mapping the Terrain Thailand’s first National Biotechnology Policy Framework served as a roadmap for significant progress, but it had a rocky start. A look back at the Framework provides signposts to guide the way forward. By Thana Poopat and Nantiya Tangwisutijit During the past 3 decades, Thailand has increasingly prioritized biotechnology investment. From medicine to food to plastics to energy, Thailand has emerg
Scientific Community Finds Value In Diversity Training
Karen Young Kreeger | Feb 16, 1997 | 10+ min read
Sidebar : For More Information on Diversity Training Groups February is Black History Month. To commemorate the occasion, employees at South San Francisco, Calif.-based Genentech Inc. have been taking part in activities that introduce them to African American culture. Members of African Americans in Biotechnology, one of the biotech firm's internal employee associations, have put together displays about the contribution of black scientists and sponsored lectures by prominent black investigators
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
Notebook
The Scientist Staff | Dec 7, 1997 | 7 min read
November was a rollercoaster month at the National Academy of Sciences (NAS). First, the United States Supreme Court declined to hear NASA's appeal of a lower court ruling subjecting the academy and its committees to the Federal Advisory Committees Act (FACA) of 1972. Animal rights groups argued that under FACA there should have been more public representation on a committee set up to revise the NIH Guide for the Care and Use of Laboratory Animals (R. Finn, The Scientist, July 22, 1996, page 1)
AIDS Researchers, Activists Wary Of Newspaper Article's Message
Steven Benowitz | Jun 9, 1996 | 10+ min read
Despite contrary suggestions, they say CDC's prevention efforts aimed toward general public were not wasted A recent article in the Wall Street Journal is causing concern in the AIDS research community. The article, titled "AIDS Fight Is Skewed By Federal Campaign Exaggerating Risks" (A. Bennett, A. Sharpe, May 1, 1996, page 1), contends that the federal Centers for Disease Control and Prevention (CDC) in Atlanta has distorted the public's perception of the potential for contracting AIDS with a
Notebook
The Scientist Staff | May 25, 1997 | 7 min read
Nobel laureate David Baltimore will assume the presidency of the California Institute of Technology this fall. Baltimore, 59, tells The Scientist he is leaving his post as a professor of molecular biology and immunology at the Massachusetts Institute of Technology, where he has been since 1994, because Caltech is "one of the premier scientific organizations in the world." Baltimore's tenure as president of Rockefeller University in New York lasted just 18 months; he resigned in late 1991 in the
Ho, Varmus Address Serious Issues at Commencements
Eugene Russo | Jul 5, 1998 | 7 min read
Commencement ceremonies this spring at many colleges and universities across the country honored not only graduating students, but scientists hailing from a variety of fields. In recognition of their achievements, dozens of scientists received honorary degrees; some also offered words of advice to graduates. The speeches included the usual all-important cliches: Strive to be your best. Take risks. Seize opportunities. Retain your individuality. Learn for the sake of learning. However, several s

Run a Search

ADVERTISEMENT